3,6,9,15-Tetraazabicyclo[9.3.1]pentadeca-1(15),11,13-triene, hydrobromide (1:3) [Pyclen Trihydrobromide]

3,6,9,15-Tetraazabicyclo[9.3.1]pentadeca-1(15),11,13-triene, hydrobromide (1:3) [Pyclen Trihydrobromide]

Products
3,6,9,15-Tetraazabicyclo[9.3.1]pentadeca-1(15),11,13-triene, hydrobromide (1:3) [Pyclen Trihydrobromide]
3,6,9,15-Tetraazabicyclo[9.3.1]pentadeca-1(15),11,13-triene, hydrobromide (1:3) [Pyclen Trihydrobromide]

Information

It is used in the synthesis of contrast agents.
Distribution Areas
OceaniaNorth America (USA, Canada)AfricaMiddle East Region (e.g. UAE)Central America (e.g. Mexico)East Asia (e.g. China, Japan, Korea)Europe - EU countriesEurope - non EU (e.g. UK, Russia, ex-CIS countries)South America (e.g. Brazil, Colombia)South Asia (e.g. India, Pakistan, Sri Lanka)South East Asia (e.g. Thailand, Philippines, Singapore)
Supplied From
China
All categories
Intermediates, Fine and Specialty ChemicalsAdvanced IntermediatesProducts
Main Categories
Intermediates, Fine and Specialty Chemicals
Shanghai Eyougene Biotechnology Development Co., LtdEstablished in 2002, Hangzhou FST Pharmaceutical focuses on advanced intermediates, APIs, and nutraceuticals. In 2022, it was acquired by Shanghai Eyougene Biotechnology, founded by top Fudan University graduates. Eyougene excels in digital CDMO services for advanced intermediates and new materials. The group has R&D centers in Shanghai, Xi'an, and Wuhan, with 382 employees, including 169 R&D and QA professionals. Located in Jiande Hangzhou, the factory complies with GMP and holds ISO9001:2000, ISO14001, and OHSAS18001 certifications.

Log in

See all the content and easy-to-use features by logging in or registering!